agence france-presse
click here to return to agence france-presse main menu
DonateNow



Thailand, China, Brazil among six nations to join cheap AIDS drugs pact

Agence France-Presse - July 14, 2004


BANGKOK, July 14 (AFP) - Six nations facing serious HIV/AIDS epidemics have forged a pact promoting low-cost drugs, officials at the world AIDS forum said Wednesday.

Three of the six, China, Thailand and Brazil, are among the world's biggest copycat drug makers and their pact aims to treat up to 10 million new patients.

The list is completed by Russia, Nigeria and Ukraine, and they could endorse a pact agreed through the World Trade Organization in 2001 that allows countries with a health crisis to break patents.

Agreement has been reached but the deal is yet to be signed, said officials.

"This is a cooperation among developing countries. This is not an anti-US network," said Pakdee Pothisiri, deputy permanent secretary of Thailand's health ministry.

"This cooperation will increase the potential in developing and producing the generic drugs," Pakdee said.

The United States has pursued a policy of protecting patents held by drug makers, many of which are US pharmaceutical companies, and having drug companies work out bilateral agreements to sell drugs cheaply to poor countries.

But some of the countries in the pact, such as Brazil, which proposed the pact, appears to favour breaking patent agreements.

"Public health must come before commercial (interests)," Alexandre Domingues Grangeiro, director of the Brazil Health Ministry's National AIDS Programme, was quoted as saying by The Nation paper in Bangkok.

However, some countries in the pact were reluctant to break patents even though they supported the idea of cheaper drugs.

China, which is a top exporter of raw materials for AIDS drugs, could lose its right to export the materials if it promotes the invokes the compulsory licence.

"It would be a big loss for us if we cannot export," said Ren Minghui, of the Chinese health ministry.

Some countries in the pact are already producing generic versions of patented drugs but an agreement is expected to lead to increased production.

Prices of the anti-AIDS drugs in those countries have dropped by as much as 80 percent.

India and South Africa were making final decisions on joining the pact, The Nation said.

040714
AF0407D4


©AFP 2004.. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission.  http://www.afp.com/

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, the National Library of Medicine, Bridgestone Firestone Trust Fund and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

©1990, 2004 - AEGiS. AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.